[go: up one dir, main page]

FI881952L - Ett foerenklat foerfarande foer produktion av moerdarceller, som aktiverats av humant lymfokin. - Google Patents

Ett foerenklat foerfarande foer produktion av moerdarceller, som aktiverats av humant lymfokin. Download PDF

Info

Publication number
FI881952L
FI881952L FI881952A FI881952A FI881952L FI 881952 L FI881952 L FI 881952L FI 881952 A FI881952 A FI 881952A FI 881952 A FI881952 A FI 881952A FI 881952 L FI881952 L FI 881952L
Authority
FI
Finland
Prior art keywords
moerdarceller
lymfokin
foerenklat
aktiverats
humant
Prior art date
Application number
FI881952A
Other languages
English (en)
Finnish (fi)
Other versions
FI881952A0 (fi
Inventor
Jr George Franks Dunn
Joseph David Irr
Lise Nadine Halpern
Original Assignee
Du Pont
Haemonetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont, Haemonetics Corp filed Critical Du Pont
Publication of FI881952A0 publication Critical patent/FI881952A0/fi
Publication of FI881952L publication Critical patent/FI881952L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081—Purging biological preparations of unwanted cells
    • C12N5/0087—Purging against subsets of blood cells, e.g. purging alloreactive T cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Peptides Or Proteins (AREA)
FI881952A 1987-04-27 1988-04-26 Ett foerenklat foerfarande foer produktion av moerdarceller, som aktiverats av humant lymfokin. FI881952L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/042,998 US4808151A (en) 1987-04-27 1987-04-27 Simplified method for the preparation of human lymphokine activated killer cells

Publications (2)

Publication Number Publication Date
FI881952A0 FI881952A0 (fi) 1988-04-26
FI881952L true FI881952L (fi) 1988-10-28

Family

ID=21924902

Family Applications (1)

Application Number Title Priority Date Filing Date
FI881952A FI881952L (fi) 1987-04-27 1988-04-26 Ett foerenklat foerfarande foer produktion av moerdarceller, som aktiverats av humant lymfokin.

Country Status (17)

Country Link
US (1) US4808151A (fr)
EP (1) EP0289896B1 (fr)
JP (1) JPH0657147B2 (fr)
KR (1) KR900004422B1 (fr)
AT (1) ATE78053T1 (fr)
AU (1) AU612086B2 (fr)
CA (1) CA1304306C (fr)
DE (1) DE3872588T2 (fr)
DK (1) DK226288A (fr)
ES (1) ES2051790T3 (fr)
FI (1) FI881952L (fr)
HU (1) HU205380B (fr)
IL (1) IL86177A0 (fr)
NO (1) NO881819L (fr)
NZ (1) NZ224379A (fr)
PT (1) PT87335B (fr)
ZA (1) ZA882948B (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7873187A (en) * 1986-08-08 1988-02-24 University Of Minnesota Method of culturing leukocytes
AU4485089A (en) * 1988-10-21 1990-05-14 Brigham And Women's Hospital Activation and growth of human tumor-infiltrating lymphocytes using antibodies to cd3 or tcr
JP2955314B2 (ja) * 1988-10-27 1999-10-04 リージェンツ・オブ・ザ・ユニバーシティー・オブ・ミネソタ Ｉｌ―２含有リポソーム免疫アジュバント
US5484396A (en) * 1988-11-17 1996-01-16 Naficy; Sadeque S. Method and device for treatment of HIV infections and AIDS
DK0460065T3 (da) * 1989-02-21 1994-09-26 Terumo Corp Fremgangsmåde til at fremkalde formering af CD4-lymfocytter
US5912170A (en) * 1991-03-07 1999-06-15 The General Hospital Corporation Redirection of cellular immunity by protein-tyrosine kinase chimeras
US7049136B2 (en) 1991-03-07 2006-05-23 The General Hospital Corporation Redirection of cellular immunity by receptor chimeras
US6004811A (en) 1991-03-07 1999-12-21 The Massachussetts General Hospital Redirection of cellular immunity by protein tyrosine kinase chimeras
US5843728A (en) * 1991-03-07 1998-12-01 The General Hospital Corporation Redirection of cellular immunity by receptor chimeras
US5851828A (en) * 1991-03-07 1998-12-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US6753162B1 (en) 1991-03-07 2004-06-22 The General Hospital Corporation Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
US5725855A (en) * 1991-04-05 1998-03-10 The United States Of America As Represented By The Department Of Health And Human Services Method of treating tumors with CD8+ -depleted or CD4+ T cell subpopulations
JPH06506465A (ja) * 1991-04-05 1994-07-21 リージエンツ・オブ・ザ・ユニバーシテイ・オブ・ミネソタ 細胞サブセットの欠落／陽性選択による免疫細胞の免疫療法活性の増強方法
IE922233A1 (en) * 1991-07-10 1993-01-13 Augusto C Ochoa Short-term anti-cd3 stimulation of lymphocytes to increase¹their in vivo activity
JPH07502734A (ja) * 1991-12-31 1995-03-23 ザイモジェネティクス，インコーポレイティド 血液損失を減少する方法および組成物
US5913768A (en) * 1995-04-18 1999-06-22 Cobe Laboratories, Inc. Particle filter apparatus
DE69637310T2 (de) * 1995-04-18 2008-08-28 Gambro BCT, Inc., Lakewood Vorrichtung und Verfahren zur Teilchentrennung
US5674173A (en) * 1995-04-18 1997-10-07 Cobe Laboratories, Inc. Apparatus for separating particles
US6053856A (en) * 1995-04-18 2000-04-25 Cobe Laboratories Tubing set apparatus and method for separation of fluid components
US6022306A (en) * 1995-04-18 2000-02-08 Cobe Laboratories, Inc. Method and apparatus for collecting hyperconcentrated platelets
US20020182730A1 (en) * 1995-07-26 2002-12-05 Micheal L. Gruenberg Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
US6051146A (en) * 1998-01-20 2000-04-18 Cobe Laboratories, Inc. Methods for separation of particles
US6153113A (en) * 1999-02-22 2000-11-28 Cobe Laboratories, Inc. Method for using ligands in particle separation
US6334842B1 (en) 1999-03-16 2002-01-01 Gambro, Inc. Centrifugal separation apparatus and method for separating fluid components
US6354986B1 (en) 2000-02-16 2002-03-12 Gambro, Inc. Reverse-flow chamber purging during centrifugal separation
FR2821947B1 (fr) * 2001-03-12 2003-05-16 Canon Kk Procede et dispositif de validation de parametres definissant une image
US20030134341A1 (en) * 2001-09-19 2003-07-17 Medcell Biologics, Llc. Th1 cell adoptive immunotherapy
US20030134415A1 (en) * 2001-09-19 2003-07-17 Gruenberg Micheal L. Th1 cell adoptive immunotherapy
US7201848B2 (en) * 2001-12-05 2007-04-10 Gambro Bct, Inc. Methods and apparatus for separation of particles
US20030173274A1 (en) * 2002-02-01 2003-09-18 Frank Corbin Blood component separation device, system, and method including filtration
US20030175272A1 (en) * 2002-03-07 2003-09-18 Medcell Biologics, Inc. Re-activated T-cells for adoptive immunotherapy
DE60318418T2 (de) * 2002-04-16 2009-01-02 Gambro BCT, Inc., Lakewood System und verfahren zur aufarbeitung von blutbestandteilen
CN1291231C (zh) 2003-12-08 2006-12-20 胡军 活化淋巴细胞特异性的检测方法
US20080035585A1 (en) * 2006-08-10 2008-02-14 Gambro Bct, Inc. Method and Apparatus for Recirculating Elutriation Fluids
DE102011106914B4 (de) 2011-07-08 2015-08-27 Zellwerk Gmbh Mäander- Bioreaktor und Verfahren zu dynamischen Expansion, Differenzierung und Ernte von hämatopoetischen Zellen
WO2014127122A1 (fr) 2013-02-18 2014-08-21 Terumo Bct, Inc. Système de séparation du sang équipé d'une chambre comportant un clapet interne à gravité
WO2017209498A1 (fr) * 2016-06-03 2017-12-07 주식회사 젬백스앤카엘 Procédé de production d'une cellule tueuse induite par cytokine pour thérapie anticancéreuse

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145713A (en) * 1963-09-12 1964-08-25 Protein Foundation Inc Method and apparatus for processing blood
US4197847A (en) * 1977-03-31 1980-04-15 Isaac Djerassi Method and apparatus for collecting transfusable granulocytes
US4185629A (en) * 1977-10-18 1980-01-29 Baxter Travenol Laboratories, Inc. Method and apparatus for processing blood
US4151844A (en) * 1977-11-11 1979-05-01 Baxter Travenol Laboratories, Inc. Method and apparatus for separating whole blood into its components and for automatically collecting one component
US4285464A (en) * 1979-01-22 1981-08-25 Haemonetics Corporation Apparatus for separation of blood into components thereof
US4401756A (en) * 1981-04-14 1983-08-30 Immunex Corporation Process for preparing human interleukin 2
US4464166A (en) * 1981-06-12 1984-08-07 Frederic A. Bourke, Jr. Method for externally treating the blood
US4464167A (en) * 1981-09-03 1984-08-07 Haemonetics Corporation Pheresis apparatus
US4416654A (en) * 1981-09-03 1983-11-22 Haemonetics Corporation Pheresis apparatus
JPS5998015A (ja) * 1982-11-27 1984-06-06 Microbial Chem Res Found 免疫賦活剤
US4613322A (en) * 1982-12-08 1986-09-23 Edelson Richard Leslie Method and system for externally treating the blood
US4683889A (en) * 1983-03-29 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
US4675383A (en) * 1983-11-15 1987-06-23 The Salk Institute For Biological Studies Purification of T-cell growth factor
US4578056A (en) * 1984-10-29 1986-03-25 Extracorporeal Medical Specialties, Inc. Patient photopheresis treatment apparatus and method
US4690915A (en) * 1985-08-08 1987-09-01 The United States Of America As Represented By The Department Of Health And Human Services Adoptive immunotherapy as a treatment modality in humans

Also Published As

Publication number Publication date
FI881952A0 (fi) 1988-04-26
EP0289896B1 (fr) 1992-07-08
US4808151A (en) 1989-02-28
ATE78053T1 (de) 1992-07-15
EP0289896A1 (fr) 1988-11-09
PT87335B (pt) 1992-08-31
DE3872588D1 (de) 1992-08-13
JPH0657147B2 (ja) 1994-08-03
KR900004422B1 (ko) 1990-06-25
NZ224379A (en) 1990-12-21
JPS63295510A (ja) 1988-12-01
ES2051790T3 (es) 1994-07-01
NO881819D0 (no) 1988-04-26
DK226288A (da) 1988-10-28
DE3872588T2 (de) 1992-12-03
PT87335A (pt) 1988-05-01
NO881819L (no) 1988-10-28
KR880012751A (ko) 1988-11-29
IL86177A0 (en) 1988-11-15
ZA882948B (en) 1989-12-27
HU205380B (en) 1992-04-28
AU1520088A (en) 1988-10-27
AU612086B2 (en) 1991-06-27
CA1304306C (fr) 1992-06-30
DK226288D0 (da) 1988-04-26

Similar Documents

Publication Publication Date Title
FI881952L (fi) Ett foerenklat foerfarande foer produktion av moerdarceller, som aktiverats av humant lymfokin.
FI864943A (fi) Abonnentenhet foer ett traodloest, digitaliskt telefonsystem.
FI910054A0 (fi) Cellstruktur, speciellt ett katalysatorsubstrat, bestaoende av ett flertal sammanvridna plaotstaplar.
FI855198A0 (fi) Foerfarande foer styrning av uppvaermningsfoerloppet foer en i ett kokkaerl befintlig, vaetskeformig last.
FI880916A (fi) Anordning foer stabilisering av en materialbana, isynnerhet foer stabilisering av en pappersbana i torkpartiet i en pappersmaskin.
FI885454L (fi) Administrationssystem, som laongsamt frigoer substituerade dihydropyridiner.
FI885346A0 (fi) Ergolinderivat, som foerhindrar parkinsons sjukdom.
FI881895L (fi) Roerkapningsverktyg som fungerar i ett borrhaol.
FI885070A0 (fi) Fotohaerdbar elektrostatisk tryckskiva, som innehaoller elektronacceptor eller -donator.
FI870266A (fi) Foerfarande foer framstaellning av ett aromatiskt koncentrat laempligt att anvaendas som skyddskomponenter i foergasarbraenslen.
FI873195L (fi) Bisukaberin, foerfarande foer produktion av denna foerening och dess anvaendning som laekemedel.
FI883733L (fi) Foerfarande foer maetning av motstaond, saerskilt motstaond i abonnentanslutningsledningar i ett digitaliskt tidsuppdelningstelekommunikationsnaet.
FI883692A0 (fi) Foerfarande foer framstaellning av ett utvaertes applicerbart, antiviralt farmaceutiskt preparat som accumuleras i huden.
FI881241A0 (fi) Laettkonstruktionskaerna, saerskilt som stoedkaerna i skida.
FI884154L (fi) Elmaskin, som innefattar slitskilar.
FI881043A (fi) Hypokolesteroliskt gelpreparat, som innehaoller ett farmaceutiskt godtagbart icke smaeltande anjonbytarharts.
FI880840A0 (fi) Anvaendning av ett aemne vilket foerhindrar aeggcellens mognad, som preventivmedel.
FI870775A0 (fi) Skivformig displaykonstruktion, i synnerhet elektroluminensdisplaykonstruktion.
FI884900L (fi) Foerfarande foer framstaellning av konstgjorda fiberarmeringar innehaollande kroppar av haordnande materialblandningar, samt produktion av fibrer foer anvaendning i dessa.
FI870398A0 (fi) Foerfarande foer avlaegsnande av ett hydrofobt aemne, i synnerhet olja, fraon en vattenyta.
FI854679A (fi) Anordning foer styrning av ett undervattensfoeremaol, som skall bogseras.
FI872399A0 (fi) Metalliskt, kopparbaserat bindemedel foer framstaellning av ett arbetsskikt foer slipverktyg.
FI882467A (fi) Proevnings- och underhaollsanordning foer en cylindrisk behaollare, speciellt ett reaktortryckkaerl.
FI860387A0 (fi) Terraengfordon, i synnerhet ett amfibiefordon.
FI871456L (fi) Anordning foer surrning av ett fordons last, t.ex. timmerstockar.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: HAEMONETICS CORPORATION

Owner name: E.I. DU PONT DE NEMOURS AND COMPANY